Tobias Hohl, MD PhD
banner
fungalspore.bsky.social
Tobias Hohl, MD PhD
@fungalspore.bsky.social
Physician-Scientist at Memorial Sloan Kettering, Chief, ID Service Member, HOPP. Lab: Mycology & Immunology. Duke ‘93 and Tri-Institutional MD-PhD ‘01 Grad. Immigrant🇨🇭. ❤️ 🐕‍🦺, 🍄‍🟫, NPR, and Catskills. Comments = do not represent views of MSKCC.
And a real doozy from the article:

"Most botanists from the mid-19th century viewed their study as a research backwater."

We're working hard here to change this long-held stereotype!
March 26, 2025 at 2:39 AM
March 21, 2025 at 8:02 PM
Love the generations!!
January 24, 2025 at 11:32 PM
Validate User
doi.org
January 10, 2025 at 1:42 AM
It's reasonable to give 5 mg/kg ambisone + posa up front since posa load takes time. I generally don't use prolonged (>2 weeks) dual therapy for mucormycosis. I don't use 10 mg/kg for mucormycosis due to toxicities. The key here is to get isolate and perform AST to optimize therapy quickly.
January 9, 2025 at 9:05 PM
If Mucorales are in the picture, I do not think that posa and isavu are equivalent. Posa IMHO is a better drug than isavu. For aspergillosis, posa and vori are my top choices, isavu OK too. I only use isavu when patient cannot tolerate posa or vori.
January 9, 2025 at 8:37 PM
Acute-angle branching is mot consistent with aspergillosis. Were septations present? I would treat with posaconazole which is enriched in CNS-penetrating neutrophils. For a very, very long time. Would try to culture tissue for isolate for ID.
January 9, 2025 at 2:36 PM
Terrific opportunity with wonderful colleagues!
November 26, 2024 at 8:38 PM
No need to duplicate. You're much further along. Just grab from mine...
November 23, 2024 at 5:11 PM
Welcome aboard!
November 22, 2024 at 1:37 PM
Would add @lableibundgut.bsky.social to the Mycology community.
November 20, 2024 at 12:51 PM
I'd start here...https://go.bsky.app/FYRJn6M
November 20, 2024 at 1:59 AM